Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind, randomized study | Zendy

Soo Jin Park | Zendy; Ga Won Yim | Zendy; Haerin Paik | Zendy; Nara Lee | Zendy; Seungmee Lee | Zendy; Maria Lee | Zendy; Hee Seung Kim | Zendy

Open Access

Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind, randomized study

Author(s) -

Soo Jin Park,

Ga Won Yim,

Haerin Paik,

Nara Lee,

Seungmee Lee,

Maria Lee,

Hee Seung Kim

Publication year - 2021

Publication title -

journal of gynecologic oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.358

H-Index - 37

eISSN - 2005-0399

pISSN - 2005-0380

DOI - 10.3802/jgo.2021.32.e73

Subject(s) - medicine , carboplatin , ovarian cancer , common terminology criteria for adverse events , chemotherapy induced peripheral neuropathy , bevacizumab , clinical endpoint , oncology , chemotherapy , paclitaxel , peripheral neuropathy , adverse effect , fallopian tube cancer , gynecologic oncology , randomized controlled trial , surgery , cancer , cisplatin , endocrinology , diabetes mellitus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research